Revelation Biosciences, Inc. (REVB)

NASDAQ

$3.71

$-0.08

(-2.13%)

After-Hours

Revelation Biosciences, Inc. (REVB) Live Price Chart

Last updated: ⁦2026-10-21 20:50:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Revelation Biosciences, Inc. (REVB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.71, with a market capitalization of $267.06K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.08 to $40.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$267.06K
Open	$3.69
Day's High	$13,759,200.00
Day's Low	$3.08
Previous Close	$3.75
Volume	5.70K
Average Volume	9.32K
P/E Ratio	--
52-Week High	$40.60
52-Week Low	$3.08
Dividend Yield	--
Earnings Date	--

Revelation Biosciences, Inc. (REVB) After-Hours Stock Price

Revelation Biosciences, Inc. (REVB) is trading at $3.73 in after-hours trading as of 2026-10-21 20:42:00, down 0.67% ($0.02) from the regular-session close of $3.75.

After-hours trading shows how investors are pricing REVB after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Revelation Biosciences, Inc. (REVB) 7-Day Stock Price Change

Over the past seven days, Revelation Biosciences, Inc. (REVB) moved from $5.42 to $3.71, representing a decline of 31.68% ($1.72).

The stock traded between $3.08 and $5.59 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 43.37 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

REVB 52-Week Price Position

Position in Range: 1.7%

52W Low$3.08

52W High$40.60

REVB is currently trading at $3.71, placing it 1.7% of the way from its 52-week low of $3.08 to its 52-week high of $40.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Revelation Biosciences, Inc. (REVB)?

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Revelation Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	9
Exchange	NASDAQ
Company Website	https://www.revbiosciences.com

How to Buy Revelation Biosciences, Inc. (REVB) Stock on MEXC

Eligible investors can buy real shares of Revelation Biosciences, Inc. (REVB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for REVB and Place Your Order

Open the RealStocks trading page and search for REVB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Revelation Biosciences, Inc. (REVB) stock price today?

Revelation Biosciences, Inc. (REVB) is currently trading at $ 3.71, down 1.20% ($0.04) from the previous close of $ 3.75. Intraday prices update in real time during regular trading hours.

2.Is REVB stock going up or down today?

As of 2026-10-21 20:42:00, REVB is trading at $ 3.71, down 1.20% ($0.04) from its previous close of $ 3.75. The stock has traded between $ 3.08 and $ 13,759,200.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is REVB pre-market price?

As of 2026-10-21 20:42:00, REVB is trading at $ 3.76 in pre-market trading, up 0.27% ($0.01) from the previous close of $ 3.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is REVB after-hours price?

As of 2026-10-21 20:42:00, REVB is trading at $ 3.73 in after-hours trading, down 0.67% ($0.02) from the regular-session close of $ 3.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is REVB stock trading now?

REVB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does REVB sit relative to its 52-week high and low?

Over the past 52 weeks, REVB has traded between a low of $ 3.08 and a high of $ 40.60. At $ 3.71, the stock is positioned 1.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Revelation Biosciences, Inc. in?

Revelation Biosciences, Inc. (REVB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Revelation Biosciences, Inc.'s market capitalization and where is it listed?

Revelation Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 267.06K. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is REVB valued in terms of P/E ratio and EPS?

REVB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -33.74. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Revelation Biosciences, Inc. pay a dividend?

Revelation Biosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.